Well said TT !I hope your barbs strike home ,and rattle a few executives. The PR "budget ? " has been swallowed by the Trial costs no doubt.I believe Relenza is still selling tho, on country demand basis.
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive